Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine
Clinical trial NCT04408794 · COMPLETED
Trial details
- NCT number
- NCT04408794
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-29
- Primary completion
- 2021-12-09
- Enrollment
- 974
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.